Christopher Morabito is Chief Medical Officer of Fulcrum Therapeutics, Inc.. Currently has a direct ownership of 1,100 shares of FULC, which is worth approximately $4,785. The most recent transaction as insider was on Jun 28, 2021, when has been sold 1,100 shares (Common Stock) at a price of $9.16 per share, resulting in proceeds of $10,076. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.1K
0% 3M change
0% 12M change
Total Value Held $4,785

Christopher Morabito Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 28 2021
BUY
Open market or private purchase
$10,076 $9.16 p/Share
1,100 Added 50.0%
1,100 Common Stock

Also insider at

ATXS
Astria Therapeutics, Inc. Healthcare
CM

Christopher Morabito

Chief Medical Officer
Boston, MA

Track Institutional and Insider Activities on FULC

Follow Fulcrum Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FULC shares.

Notify only if

Insider Trading

Get notified when an Fulcrum Therapeutics, Inc. insider buys or sells FULC shares.

Notify only if

News

Receive news related to Fulcrum Therapeutics, Inc.

Track Activities on FULC